alexa Cytokine Arrays Reveal ?Black Ops? Tactics Of Tumor-induced Immunosuppression
ISSN: 2155-9899

Journal of Clinical & Cellular Immunology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference and Exhibition on Clinical & Cellular Immunology
September 29-October 01, 2014 DoubleTree by Hilton Baltimore-BWI Airport, USA

Ruo-Pan Huang
ScientificTracks Abstracts: J Clin Cell Immunol
DOI: 10.4172/2155-9899.S1.017
Abstract
The immune system continuously scans for foreign substances on pathogens and aberrant cells and targets them for elimination. To persist and grow, tumors must evade or sabotage this constant immunosurveillance. The mechanisms of innate and adaptive immune response and of tumor-induced immunosuppression involve complex networks of many different cell types that are regulated and coordinated by numerous cytokines and other related secreted proteins. Much of our current understanding of these complex interactions have come through the dissection of cell-cell communication networks in the tumor microenvironment using multiplexed protein detection, such as cytokine antibody arrays, which can detect expression of dozens or hundreds of proteins in a single experiment. This presentation will give examples of the investigative power of cytokine antibody arrays to help identify key factors in complex biological mechanisms in conjunction with more classical methods of cellular and molecular biology. Additionally, a model of tumor-induced immunosuppression, suggested by the collective results of such experiments, will be presented along with the implications of this model for future investigations of cancer immunology.
Biography
Ruo-Pan Huang is a founder and CEO of RayBiotech, Inc and adjunct Associate Professor of Emory University. As a pioneer in the development of protein array technology, he and his team have developed many innovative protein array technologies and products which now are widely used worldwide by many investigators. He has published about 100 scientifi c research papers. He also serves on the editorial board of several journals such as Cancer Genomics and Proteomics, journal of analytical oncology and open journal of proteomics and on several other committees, including an NIH study section and Chinese National Natural Science Fund. His research has been funded by NIH, ACS, Emory University and others. During his tenure, he has received several awards, including the American Cancer Society Young Investigator Award
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords